Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2B
Enterprise Value2.74B
P/E Ratio-18.31
PEG Ratio0.41
Price/Sales Ratio1.99
Price/Book Ratio1.15
Enterprise/Revenue2.69
Enterprise/EBITDA88.85

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.11
Operating Margin-0.11
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.06

Income Statement

Revenue940.19M
Revenue/Share8.93
Gross Profit222.07M
EBITDA84.1M
Net Income-82.39M
Diluted EPS-0.73

Balance Sheet

Total Cash368.54M
Total Cash/Share3.25
Total Debt1.02B
Total Debt/Equity0.58
Current Ratio1.87
Book Value Per Share15.62

Price History

52-Week Change1.24
52-Week High24.7
52-Week Low17.06
Moving Average 50 Days21.13
Moving Average 200 Days20.57

Statistics

Average Volume3.95M
Shares Outstanding112.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.05
Last Split FactorN/A
Last Split DateN/A
AD